FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

385084005: Conventional release sublingual tablet (dose form)

Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jan 2018. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
1479346016 Sublingual tablet en Synonym Active Entire term case insensitive SNOMED CT core module
3633870019 Conventional release sublingual tablet (dose form) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3633871015 Conventional release sublingual tablet en Synonym Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Conventional release sublingual tablet Is a Tablet false Inferred relationship Existential restriction modifier
Conventional release sublingual tablet Is a Oromucosal AND/OR gingival dosage form false Inferred relationship Existential restriction modifier
Conventional release sublingual tablet Is a Tablet false Inferred relationship Existential restriction modifier
Conventional release sublingual tablet Is a Conventional release orodispersible tablet false Inferred relationship Existential restriction modifier
Conventional release sublingual tablet Has dose form administration method Administer true Inferred relationship Existential restriction modifier
Conventional release sublingual tablet Has dose form intended site Sublingual true Inferred relationship Existential restriction modifier
Conventional release sublingual tablet Has dose form release characteristic Conventional release true Inferred relationship Existential restriction modifier
Conventional release sublingual tablet Has basic dose form Tablet true Inferred relationship Existential restriction modifier
Conventional release sublingual tablet Is a Sublingual dose form true Inferred relationship Existential restriction modifier
Conventional release sublingual tablet Has dose form transformation No transformation true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely glyceryl trinitrate 2 milligram/1 each prolonged-release buccal tablet (clinical drug) Has manufactured dose form False Conventional release sublingual tablet Inferred relationship Existential restriction modifier
Product containing precisely glyceryl trinitrate 1 milligram/1 each prolonged-release buccal tablet (clinical drug) Has manufactured dose form False Conventional release sublingual tablet Inferred relationship Existential restriction modifier
Product containing precisely glyceryl trinitrate 3 milligram/1 each prolonged-release buccal tablet (clinical drug) Has manufactured dose form False Conventional release sublingual tablet Inferred relationship Existential restriction modifier
Product containing precisely glyceryl trinitrate 5 milligram/1 each prolonged-release buccal tablet (clinical drug) Has manufactured dose form False Conventional release sublingual tablet Inferred relationship Existential restriction modifier
Product containing precisely glyceryl trinitrate 1.5 milligram/1 each prolonged-release buccal tablet (clinical drug) Has manufactured dose form False Conventional release sublingual tablet Inferred relationship Existential restriction modifier
Nitroglycerin 300micrograms tablet Has manufactured dose form False Conventional release sublingual tablet Inferred relationship Existential restriction modifier
Product containing precisely glyceryl trinitrate 400 microgram/1 each conventional release sublingual tablet (clinical drug) Has manufactured dose form True Conventional release sublingual tablet Inferred relationship Existential restriction modifier
Nitroglycerin 0.6mg tablet Has manufactured dose form False Conventional release sublingual tablet Inferred relationship Existential restriction modifier
Isosorbide dinitrate 5mg sublingual tablet Has manufactured dose form False Conventional release sublingual tablet Inferred relationship Existential restriction modifier
Product containing precisely isosorbide dinitrate 10 milligram/1 each conventional release sublingual tablet (clinical drug) Has manufactured dose form True Conventional release sublingual tablet Inferred relationship Existential restriction modifier
Product containing precisely isosorbide dinitrate 5 milligram/1 each conventional release sublingual tablet (clinical drug) Has manufactured dose form True Conventional release sublingual tablet Inferred relationship Existential restriction modifier
Product containing precisely isosorbide dinitrate 2.5 milligram/1 each conventional release sublingual tablet (clinical drug) Has manufactured dose form True Conventional release sublingual tablet Inferred relationship Existential restriction modifier
Product containing precisely apomorphine hydrochloride 3 milligram/1 each conventional release sublingual tablet Has manufactured dose form False Conventional release sublingual tablet Inferred relationship Existential restriction modifier
Product containing precisely apomorphine hydrochloride 2 milligram/1 each conventional release sublingual tablet Has manufactured dose form False Conventional release sublingual tablet Inferred relationship Existential restriction modifier
Zolpidem 5mg sublingual tablet Has manufactured dose form False Conventional release sublingual tablet Inferred relationship Existential restriction modifier
Zolpidem 10mg sublingual tablet Has manufactured dose form False Conventional release sublingual tablet Inferred relationship Existential restriction modifier
Nicotine 2mg sublingual tablet Has manufactured dose form False Conventional release sublingual tablet Inferred relationship Existential restriction modifier
Product containing precisely dihydroergotamine mesilate 500 microgram/1 each conventional release sublingual tablet (clinical drug) Has manufactured dose form True Conventional release sublingual tablet Inferred relationship Existential restriction modifier
Product containing precisely dihydroergotamine mesilate 1 milligram/1 each conventional release sublingual tablet (clinical drug) Has manufactured dose form True Conventional release sublingual tablet Inferred relationship Existential restriction modifier
Buprenorphine hydrochloride 2mg + naloxone hydrochloride 0.5mg sublingual tablet Has manufactured dose form False Conventional release sublingual tablet Inferred relationship Existential restriction modifier
Buprenorphine hydrochloride 8mg + naloxone hydrochloride 2mg sublingual tablet Has manufactured dose form False Conventional release sublingual tablet Inferred relationship Existential restriction modifier
Product containing precisely ergotamine tartrate 2 milligram/1 each conventional release sublingual tablet Has manufactured dose form False Conventional release sublingual tablet Inferred relationship Existential restriction modifier
Product containing precisely buprenorphine (as buprenorphine hydrochloride) 200 microgram/1 each conventional release sublingual tablet Has manufactured dose form False Conventional release sublingual tablet Inferred relationship Existential restriction modifier
Product containing precisely buprenorphine (as buprenorphine hydrochloride) 2 milligram/1 each conventional release sublingual tablet Has manufactured dose form False Conventional release sublingual tablet Inferred relationship Existential restriction modifier
Product containing precisely buprenorphine (as buprenorphine hydrochloride) 8 milligram/1 each conventional release sublingual tablet Has manufactured dose form False Conventional release sublingual tablet Inferred relationship Existential restriction modifier
Product containing precisely buprenorphine (as buprenorphine hydrochloride) 400 microgram/1 each conventional release sublingual tablet Has manufactured dose form False Conventional release sublingual tablet Inferred relationship Existential restriction modifier
Product containing precisely asenapine 5 milligram/1 each conventional release sublingual tablet (clinical drug) Has manufactured dose form True Conventional release sublingual tablet Inferred relationship Existential restriction modifier
Product containing precisely asenapine 10 milligram/1 each conventional release sublingual tablet (clinical drug) Has manufactured dose form True Conventional release sublingual tablet Inferred relationship Existential restriction modifier
Product containing precisely glyceryl trinitrate 600 microgram/1 each conventional release sublingual tablet Has manufactured dose form False Conventional release sublingual tablet Inferred relationship Existential restriction modifier
Product containing precisely glyceryl trinitrate 300 microgram/1 each conventional release sublingual tablet Has manufactured dose form False Conventional release sublingual tablet Inferred relationship Existential restriction modifier
Product containing precisely glyceryl trinitrate 500 microgram/1 each conventional release sublingual tablet Has manufactured dose form False Conventional release sublingual tablet Inferred relationship Existential restriction modifier
Product containing precisely nicotine (as nicotine cyclodextrin complex) 2 milligram/1 each conventional release sublingual tablet Has manufactured dose form True Conventional release sublingual tablet Inferred relationship Existential restriction modifier
Product containing precisely buprenorphine (as buprenorphine hydrochloride) 8 milligram and naloxone hydrochloride 2 milligram/1 each conventional release sublingual tablet (clinical drug) Has manufactured dose form True Conventional release sublingual tablet Inferred relationship Existential restriction modifier
Product containing precisely buprenorphine 2 milligram and naloxone hydrochloride 500 microgram/1 each conventional release sublingual tablet (clinical drug) Has manufactured dose form True Conventional release sublingual tablet Inferred relationship Existential restriction modifier
Product containing precisely zolpidem tartrate 10 milligram/1 each conventional release sublingual tablet (clinical drug) Has manufactured dose form True Conventional release sublingual tablet Inferred relationship Existential restriction modifier
Product containing precisely zolpidem tartrate 5 milligram/1 each conventional release sublingual tablet (clinical drug) Has manufactured dose form True Conventional release sublingual tablet Inferred relationship Existential restriction modifier
Subutex 8mg sublingual tablets (Pilsco Ltd) 7 tablet Has dispensed dose form True Conventional release sublingual tablet Inferred relationship Existential restriction modifier
Subutex 8mg sublingual tablets (Pilsco Ltd) Has dispensed dose form True Conventional release sublingual tablet Inferred relationship Existential restriction modifier
Suboxone 2mg/500microgram sublingual tablets (Ethigen Ltd) Has dispensed dose form True Conventional release sublingual tablet Inferred relationship Existential restriction modifier
Suboxone 8mg/2mg sublingual tablets (Ethigen Ltd) Has dispensed dose form True Conventional release sublingual tablet Inferred relationship Existential restriction modifier
Suboxone 8mg/2mg sublingual tablets (Ethigen Ltd) 28 tablet Has dispensed dose form True Conventional release sublingual tablet Inferred relationship Existential restriction modifier
Suboxone 2mg/500microgram sublingual tablets (Ethigen Ltd) 28 tablet Has dispensed dose form True Conventional release sublingual tablet Inferred relationship Existential restriction modifier
Product containing precisely apomorphine hydrochloride 2 milligram/1 each conventional release sublingual tablet Has manufactured dose form False Conventional release sublingual tablet Inferred relationship Existential restriction modifier
Product containing precisely glyceryl trinitrate 300 microgram/1 each conventional release sublingual tablet Has manufactured dose form False Conventional release sublingual tablet Inferred relationship Existential restriction modifier
Product containing precisely buprenorphine (as buprenorphine hydrochloride) 200 microgram/1 each conventional release sublingual tablet Has manufactured dose form False Conventional release sublingual tablet Inferred relationship Existential restriction modifier
Product containing precisely buprenorphine (as buprenorphine hydrochloride) 400 microgram/1 each conventional release sublingual tablet Has manufactured dose form False Conventional release sublingual tablet Inferred relationship Existential restriction modifier
Product containing precisely glyceryl trinitrate 600 microgram/1 each conventional release sublingual tablet Has manufactured dose form False Conventional release sublingual tablet Inferred relationship Existential restriction modifier
Product containing precisely buprenorphine (as buprenorphine hydrochloride) 2 milligram/1 each conventional release sublingual tablet Has manufactured dose form False Conventional release sublingual tablet Inferred relationship Existential restriction modifier
Product containing precisely glyceryl trinitrate 500 microgram/1 each conventional release sublingual tablet Has manufactured dose form False Conventional release sublingual tablet Inferred relationship Existential restriction modifier
Product containing precisely ergotamine tartrate 2 milligram/1 each conventional release sublingual tablet Has manufactured dose form False Conventional release sublingual tablet Inferred relationship Existential restriction modifier
Product containing precisely buprenorphine (as buprenorphine hydrochloride) 8 milligram/1 each conventional release sublingual tablet Has manufactured dose form False Conventional release sublingual tablet Inferred relationship Existential restriction modifier
Product containing precisely apomorphine hydrochloride 3 milligram/1 each conventional release sublingual tablet Has manufactured dose form False Conventional release sublingual tablet Inferred relationship Existential restriction modifier
Buprenorphine 2mg / Naloxone 500microgram sublingual tablets sugar free (DE Pharmaceuticals) 28 tablet Has dispensed dose form True Conventional release sublingual tablet Inferred relationship Existential restriction modifier
Buprenorphine 8mg / Naloxone 2mg sublingual tablets sugar free (DE Pharmaceuticals) 28 tablet Has dispensed dose form True Conventional release sublingual tablet Inferred relationship Existential restriction modifier
Buprenorphine 8mg / Naloxone 2mg sublingual tablets sugar free (DE Pharmaceuticals) Has dispensed dose form True Conventional release sublingual tablet Inferred relationship Existential restriction modifier
Buprenorphine 2mg / Naloxone 500microgram sublingual tablets sugar free (DE Pharmaceuticals) Has dispensed dose form True Conventional release sublingual tablet Inferred relationship Existential restriction modifier
Fenhuma 600microgram sublingual tablets (Glenmark Pharmaceuticals Europe Ltd) 30 tablet 3 x 10 tablets Has dispensed dose form True Conventional release sublingual tablet Inferred relationship Existential restriction modifier
Fenhuma 100microgram sublingual tablets (Glenmark Pharmaceuticals Europe Ltd) 30 tablet 3 x 10 tablets Has dispensed dose form True Conventional release sublingual tablet Inferred relationship Existential restriction modifier
Fenhuma 100microgram sublingual tablets (Glenmark Pharmaceuticals Europe Ltd) 10 tablet Has dispensed dose form True Conventional release sublingual tablet Inferred relationship Existential restriction modifier
Fenhuma 800microgram sublingual tablets (Glenmark Pharmaceuticals Europe Ltd) 30 tablet 3 x 10 tablets Has dispensed dose form True Conventional release sublingual tablet Inferred relationship Existential restriction modifier
Fenhuma 800microgram sublingual tablets (Glenmark Pharmaceuticals Europe Ltd) Has dispensed dose form True Conventional release sublingual tablet Inferred relationship Existential restriction modifier
Fenhuma 100microgram sublingual tablets (Glenmark Pharmaceuticals Europe Ltd) Has dispensed dose form True Conventional release sublingual tablet Inferred relationship Existential restriction modifier
Fenhuma 200microgram sublingual tablets (Glenmark Pharmaceuticals Europe Ltd) 30 tablet 3 x 10 tablets Has dispensed dose form True Conventional release sublingual tablet Inferred relationship Existential restriction modifier
Fenhuma 400microgram sublingual tablets (Glenmark Pharmaceuticals Europe Ltd) 30 tablet 3 x 10 tablets Has dispensed dose form True Conventional release sublingual tablet Inferred relationship Existential restriction modifier
Fenhuma 400microgram sublingual tablets (Glenmark Pharmaceuticals Europe Ltd) 10 tablet Has dispensed dose form True Conventional release sublingual tablet Inferred relationship Existential restriction modifier
Desmopressin 240microgram sublingual tablets sugar free Has dispensed dose form True Conventional release sublingual tablet Inferred relationship Existential restriction modifier
Desmopressin 60microgram sublingual tablets sugar free Has dispensed dose form True Conventional release sublingual tablet Inferred relationship Existential restriction modifier
Fenhuma 300microgram sublingual tablets (Glenmark Pharmaceuticals Europe Ltd) 10 tablet Has dispensed dose form True Conventional release sublingual tablet Inferred relationship Existential restriction modifier
Desmopressin 120microgram sublingual tablets sugar free Has dispensed dose form True Conventional release sublingual tablet Inferred relationship Existential restriction modifier
Fenhuma 300microgram sublingual tablets (Glenmark Pharmaceuticals Europe Ltd) Has dispensed dose form True Conventional release sublingual tablet Inferred relationship Existential restriction modifier
Fenhuma 600microgram sublingual tablets (Glenmark Pharmaceuticals Europe Ltd) Has dispensed dose form True Conventional release sublingual tablet Inferred relationship Existential restriction modifier
Fenhuma 400microgram sublingual tablets (Glenmark Pharmaceuticals Europe Ltd) Has dispensed dose form True Conventional release sublingual tablet Inferred relationship Existential restriction modifier
Fenhuma 200microgram sublingual tablets (Glenmark Pharmaceuticals Europe Ltd) 10 tablet Has dispensed dose form True Conventional release sublingual tablet Inferred relationship Existential restriction modifier
Fenhuma 300microgram sublingual tablets (Glenmark Pharmaceuticals Europe Ltd) 30 tablet 3 x 10 tablets Has dispensed dose form True Conventional release sublingual tablet Inferred relationship Existential restriction modifier
Desmopressin 240microgram sublingual tablets sugar free 30 tablet Has dispensed dose form True Conventional release sublingual tablet Inferred relationship Existential restriction modifier
Desmopressin 60microgram sublingual tablets sugar free (Kinedexe UK Ltd) Has dispensed dose form True Conventional release sublingual tablet Inferred relationship Existential restriction modifier
Desmopressin 60microgram sublingual tablets sugar free 100 tablet Has dispensed dose form True Conventional release sublingual tablet Inferred relationship Existential restriction modifier
Desmopressin 240microgram sublingual tablets sugar free (Kinedexe UK Ltd) Has dispensed dose form True Conventional release sublingual tablet Inferred relationship Existential restriction modifier
Desmopressin 120microgram sublingual tablets sugar free (Kinedexe UK Ltd) 30 tablet Has dispensed dose form True Conventional release sublingual tablet Inferred relationship Existential restriction modifier
Desmopressin 120microgram sublingual tablets sugar free (Kinedexe UK Ltd) Has dispensed dose form True Conventional release sublingual tablet Inferred relationship Existential restriction modifier
Desmopressin 240microgram sublingual tablets sugar free 100 tablet Has dispensed dose form True Conventional release sublingual tablet Inferred relationship Existential restriction modifier
Desmopressin 240microgram sublingual tablets sugar free (Kinedexe UK Ltd) 100 tablet Has dispensed dose form True Conventional release sublingual tablet Inferred relationship Existential restriction modifier
Desmopressin 120microgram sublingual tablets sugar free 30 tablet Has dispensed dose form True Conventional release sublingual tablet Inferred relationship Existential restriction modifier
Desmopressin 240microgram sublingual tablets sugar free (Kinedexe UK Ltd) 30 tablet Has dispensed dose form True Conventional release sublingual tablet Inferred relationship Existential restriction modifier
Desmopressin 60microgram sublingual tablets sugar free (Kinedexe UK Ltd) 100 tablet Has dispensed dose form True Conventional release sublingual tablet Inferred relationship Existential restriction modifier
Fenhuma 200microgram sublingual tablets (Glenmark Pharmaceuticals Europe Ltd) Has dispensed dose form True Conventional release sublingual tablet Inferred relationship Existential restriction modifier
Product containing precisely glyceryl trinitrate 300 microgram/1 each conventional release sublingual tablet Has manufactured dose form False Conventional release sublingual tablet Inferred relationship Existential restriction modifier
Product containing precisely glyceryl trinitrate 600 microgram/1 each conventional release sublingual tablet Has manufactured dose form False Conventional release sublingual tablet Inferred relationship Existential restriction modifier
Product containing precisely apomorphine hydrochloride 2 milligram/1 each conventional release sublingual tablet Has manufactured dose form False Conventional release sublingual tablet Inferred relationship Existential restriction modifier
Product containing precisely apomorphine hydrochloride 3 milligram/1 each conventional release sublingual tablet Has manufactured dose form False Conventional release sublingual tablet Inferred relationship Existential restriction modifier
Product containing precisely buprenorphine (as buprenorphine hydrochloride) 2 milligram/1 each conventional release sublingual tablet Has manufactured dose form False Conventional release sublingual tablet Inferred relationship Existential restriction modifier
Product containing precisely buprenorphine (as buprenorphine hydrochloride) 8 milligram/1 each conventional release sublingual tablet Has manufactured dose form False Conventional release sublingual tablet Inferred relationship Existential restriction modifier
Product containing precisely glyceryl trinitrate 500 microgram/1 each conventional release sublingual tablet Has manufactured dose form False Conventional release sublingual tablet Inferred relationship Existential restriction modifier
Product containing precisely buprenorphine (as buprenorphine hydrochloride) 400 microgram/1 each conventional release sublingual tablet Has manufactured dose form False Conventional release sublingual tablet Inferred relationship Existential restriction modifier
Product containing precisely ergotamine tartrate 2 milligram/1 each conventional release sublingual tablet Has manufactured dose form False Conventional release sublingual tablet Inferred relationship Existential restriction modifier
Product containing precisely buprenorphine (as buprenorphine hydrochloride) 200 microgram/1 each conventional release sublingual tablet Has manufactured dose form False Conventional release sublingual tablet Inferred relationship Existential restriction modifier
Subutex 8mg sublingual tablets (CST Pharma Ltd) 7 tablet Has dispensed dose form True Conventional release sublingual tablet Inferred relationship Existential restriction modifier
Subutex 8mg sublingual tablets (CST Pharma Ltd) Has dispensed dose form True Conventional release sublingual tablet Inferred relationship Existential restriction modifier
Suboxone 2mg/500microgram sublingual tablets (CST Pharma Ltd) 28 tablet Has dispensed dose form True Conventional release sublingual tablet Inferred relationship Existential restriction modifier
Suboxone 2mg/500microgram sublingual tablets (CST Pharma Ltd) Has dispensed dose form True Conventional release sublingual tablet Inferred relationship Existential restriction modifier
Suboxone 8mg/2mg sublingual tablets (CST Pharma Ltd) Has dispensed dose form True Conventional release sublingual tablet Inferred relationship Existential restriction modifier

Page 1 of 8 Next End

This concept is not in any reference sets

Back to Start